BullFrog AI Holdings, Inc. Logo

BullFrog AI Holdings, Inc.

Leverages causal AI to accelerate drug discovery and identify novel targets for biopharmaceuticals.

BFRG | US

Overview

Corporate Details

ISIN(s):
US12021E1091
LEI:
Country:
United States of America
Address:
325 ELLINGTON BLVD., 20878 GAITHERSBURG
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

BullFrog AI Holdings, Inc. is a technology-enabled biopharmaceutical company that leverages artificial intelligence (AI) and machine learning (ML) to enhance the drug discovery and development process. The company utilizes a proprietary platform featuring causal AI and graph-based analytics to model complex biological systems. This technology enables the rapid and cost-effective identification and validation of novel drug targets, aiming to generate actionable insights from complex data. By supporting both internal and external drug development programs, BullFrog AI's mission is to accelerate research, lower costs, and significantly improve the success rate of bringing new therapeutics to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BullFrog AI Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BullFrog AI Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BullFrog AI Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HALOZYME THERAPEUTICS, INC. Logo
Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.
United States of America
HALO
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan
4593
HeartSciences Inc. Logo
AI-powered ECG technology for early detection of heart disease and advanced diagnostics.
United States of America
HSCS
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan
219A
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland
HRTIS
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland
HPE
HLB bioStep Co.,Ltd. Logo
South Korea
278650
HLB PANAGENE Co., LTD. Logo
A global leader in PNA technology for cancer diagnostics and precision medicine.
South Korea
046210
HLB SCIENCE Inc. Logo
Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.
South Korea
343090
Hoth Therapeutics, Inc. Logo
Advancing therapeutics for metabolic, dermatologic, and inflammatory diseases.
United States of America
HOTH

Talk to a Data Expert

Have a question? We'll get back to you promptly.